Geneglim MP 1mg/500mg/7.5mg Tablet
Marketer
Geneaid Pharmaceuticals
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview Geneglim MP 1mg/500mg/7.5mg Tablet
Diabetic patients with type 2 mellitus may find blood sugar management improved by using the triple-combination tablet, Glytrin-MP (1mg/500mg/7.5mg). This medication, when combined with a healthy diet and regular exercise, enhances insulin effectiveness, resulting in better glycemic control. Dosage and regimen should strictly adhere to your physician's instructions; always take it with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless the next dose is imminent; never double the dose to compensate. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concurrently using other antidiabetic medications, alcohol consumption, or missed meals elevates hypoglycemia risk; therefore, regular blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, increased fracture risk, and respiratory infections. Prior to initiating treatment, individuals with hepatic, renal, or cardiac issues, pregnant or lactating women, must consult their doctor. Kidney function assessment is standard before prescription. Limit alcohol consumption to mitigate potential side effects.
Uses of Geneglim MP 1mg/500mg/7.5mg Tablet
Managing Type 2 diabetes
Major Benefits of Geneglim MP 1mg/500mg/7.5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Geneglim MP 1mg/500mg/7.5mg tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Geneglim MP 1mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Geneglim MP 1mg/500mg/7.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Geneglim MP 1mg/500mg/7.5mg tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Geneglim MP 1mg/500mg/7.5mg Tablet works:
Geneglim MP 1mg/500mg/7.5mg tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications utilize distinct pathways to optimize blood glucose management when single or dual-agent treatments prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Geneglim MP 1mg/500mg/7.5mg tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Geneglim MP 1mg/500mg/7.5mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Geneglim MP 1mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively high or low blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Geneglim MP 1mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Geneglim MP 1mg/500mg/7.5mg tablets. Medical supervision, including regular kidney function tests, is recommended during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Geneglim MP 1mg/500mg/7.5mg tablets. Dosage modification may be necessary. Medical advice is recommended. Geneglim MP 1mg/500mg/7.5mg tablets are contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Geneglim MP 1mg/500mg/7.5mg Tablet :
Should you forget to take a Geneglim MP 1mg/500mg/7.5mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Geneglim MP 1mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently